Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 5Advanced Solid Tumors 5Advanced Solid Tumour 4Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Small Cell Lung Carcinoma 2Recurrence 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2Advanced Lung Cancer 2Unresectable Locally Recurrent Breast Cancer 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Non-small Lung Cancer 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Sclerosis 1Metastatic Solid Tumors 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Idiopathic Pulmonary Fibrosis 1Digestive System Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Depression 1

Interventions

repotrectinib 1atezolizumab 1Tretinoin 1Oviposition 1Injections 1Imatinib Mesylate 1Drainage 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × Injections × 30 days × Clear all
NCT07564466 2026-05-11

A Study of SKB571 in Participants With Gastrointestinal Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 2 Not yet recruiting
120 enrolled
Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡